About this FactMed analysis covering adverse side effect reports of ACAI patients who developed HYPONATRAEMIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ACAI reported HYPONATRAEMIA to the FDA. A total of 25 ACAI drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACAI and HYPONATRAEMIA. In doing so, we compare ACAI with other drugs that cause HYPONATRAEMIA, to help you evaluate whether or not ACAI causes HYPONATRAEMIA. Likewise, this page shows the most highly-reported side effects of ACAI, so you can see if HYPONATRAEMIA ranks among ACAI's most well-known side effects.
Summary Statistics
Reports of ACAI causing HYPONATRAEMIA: 1
Reports of any side effect of ACAI : 25
Percentage of ACAI patients where HYPONATRAEMIA is a reported side effect: 4.0000%

FDA reports of any drug causing HYPONATRAEMIA : 19923
Average percentage for all medicated patients where HYPONATRAEMIA is reported as a complication: 0.1249%

Physician opinion on ACAI as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACAI:
VITAMIN SUPPLEMENTATION ( 6 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
MEDICAL DIET ( 1 patients )
ROUTINE HEALTH MAINTENANCE ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPONATRAEMIA:

ASPIRIN (2054 patients)
FOSAMAX (1495 patients)
LASIX (1365 patients)
OMEPRAZOLE (1088 patients)
HEPARIN SODIUM INJECTION (1017 patients)
FUROSEMIDE (893 patients)
HYDROCHLOROTHIAZIDE (864 patients)
CISPLATIN (809 patients)
LEVOTHYROXINE SODIUM (754 patients)
ZOMETA (753 patients)
LISINOPRIL (738 patients)
DEXAMETHASONE (719 patients)
ACETAMINOPHEN (688 patients)
PREDNISONE (686 patients)
NEXIUM (685 patients)
ALDACTONE (665 patients)
VIOXX (665 patients)
LORAZEPAM (643 patients)
SIMVASTATIN (632 patients)
PLAVIX (627 patients)
DIGOXIN (615 patients)
POTASSIUM CHLORIDE (589 patients)
COUMADIN (587 patients)
ATENOLOL (576 patients)
ALLOPURINOL (570 patients)
RAMIPRIL (568 patients)
SEROQUEL (555 patients)
AMLODIPINE (554 patients)
TRILEPTAL (553 patients)
ZOLOFT (538 patients)
CITALOPRAM HYDROBROMIDE (531 patients)
NORVASC (514 patients)
SPIRONOLACTONE (505 patients)
TEGRETOL (495 patients)
LIPITOR (493 patients)
FOLIC ACID (489 patients)
PROTONIX (486 patients)
PREDNISOLONE (480 patients)
RISPERDAL (476 patients)
DIOVAN (469 patients)
METHOTREXATE (455 patients)
NEURONTIN (444 patients)
SYNTHROID (441 patients)
DECADRON (438 patients)
VELCADE (436 patients)
CARBOPLATIN (429 patients)
ZOFRAN (422 patients)
LYRICA (417 patients)
ZYPREXA (411 patients)
PAXIL (409 patients)
CYMBALTA (403 patients)
ATIVAN (401 patients)
ZOCOR (400 patients)
MIRTAZAPINE (390 patients)
XANAX (385 patients)
ALBUTEROL (376 patients)
AMBIEN (375 patients)
PRILOSEC (368 patients)
WARFARIN SODIUM (365 patients)
FLUOROURACIL (364 patients)
METFORMIN HCL (359 patients)
CARBAMAZEPINE (358 patients)
REVLIMID (356 patients)
ENALAPRIL MALEATE (348 patients)
OXYCONTIN (347 patients)
AREDIA (347 patients)
DOCETAXEL (338 patients)
TRAMADOL HCL (330 patients)
LEVAQUIN (326 patients)
IBUPROFEN (323 patients)
LANSOPRAZOLE (317 patients)
LEXAPRO (317 patients)
EFFEXOR (307 patients)
ALENDRONATE SODIUM (302 patients)
VITAMIN D (301 patients)
METOPROLOL TARTRATE (291 patients)
KEPPRA (289 patients)
CYCLOPHOSPHAMIDE (285 patients)
BISOPROLOL FUMARATE (278 patients)
OXYCODONE HCL (277 patients)
ALPRAZOLAM (274 patients)
MORPHINE (274 patients)
GABAPENTIN (274 patients)
CLONAZEPAM (274 patients)
CELEBREX (270 patients)
PANTOPRAZOLE SODIUM (267 patients)
PREDNISONE TAB (267 patients)
LOVENOX (265 patients)
COMPAZINE (260 patients)
INDAPAMIDE (259 patients)
LACTULOSE (258 patients)
PROZAC (256 patients)
DEPAKENE (255 patients)
COREG (251 patients)
PANTOPRAZOLE (250 patients)
LANTUS (248 patients)
TOPROL-XL (247 patients)
CIPROFLOXACIN (245 patients)
CARVEDILOL (245 patients)
MAGNESIUM OXIDE (244 patients)
CORDARONE (242 patients)
REMICADE (242 patients)
METOCLOPRAMIDE (237 patients)
ESCITALOPRAM (236 patients)
ONDANSETRON (236 patients)
DURAGESIC-100 (232 patients)
VICODIN (230 patients)
CALCIUM (229 patients)
ALTACE (227 patients)
COZAAR (227 patients)
HYDROCORTISONE (226 patients)
HYZAAR (226 patients)
ZOLPIDEM (225 patients)
PREVACID (224 patients)
CAPECITABINE (224 patients)
PERCOCET (224 patients)
DIAZEPAM (220 patients)
SPIRIVA (219 patients)
SODIUM CHLORIDE (219 patients)
CETUXIMAB (218 patients)
MULTI-VITAMINS (217 patients)
GLUCOPHAGE (216 patients)
FAMOTIDINE (216 patients)
INSULIN (214 patients)
BACTRIM (213 patients)
VANCOMYCIN (210 patients)
NEXAVAR (210 patients)
CALCIUM CARBONATE (206 patients)
CRESTOR (205 patients)
TAXOTERE (205 patients)
FLUCONAZOLE (204 patients)
PAROXETINE HCL (204 patients)
BEVACIZUMAB (204 patients)
MULTI-VITAMIN (204 patients)
ADVAIR DISKUS 100/50 (203 patients)
FERROUS SULFATE TAB (201 patients)
AMOXICILLIN (200 patients)
DIFLUCAN (200 patients)
ZYVOX (198 patients)
ACTONEL (196 patients)
AMLODIPINE BESYLATE (195 patients)
SUTENT (194 patients)
TRAZODONE HCL (194 patients)
CELEXA (192 patients)
NITROGLYCERIN (192 patients)
ATACAND (189 patients)
COLACE (188 patients)
RANITIDINE (187 patients)
BENADRYL (186 patients)
KARDEGIC (184 patients)
REGLAN (183 patients)
PEPCID (182 patients)
DEROXAT (180 patients)
AVASTIN (180 patients)
FLUOXETINE (179 patients)
NEORAL (177 patients)
TAXOL (176 patients)
OXCARBAZEPINE (175 patients)
PACLITAXEL (175 patients)
RISPERIDONE (174 patients)
ERLOTINIB HYDROCHLORIDE (174 patients)
AMIODARONE HCL (174 patients)
TEMAZEPAM (172 patients)
DEXAMETHASONE TAB (171 patients)
METOPROLOL (170 patients)
OXALIPLATIN (170 patients)
VITAMIN B-12 (169 patients)
VINCRISTINE (167 patients)
ACYCLOVIR (166 patients)
LORTAB (165 patients)
HEPARIN SODIUM (164 patients)
ASCORBIC ACID (163 patients)
PREMARIN (163 patients)
OXAZEPAM (162 patients)
FENTANYL (162 patients)
ATORVASTATIN CALCIUM (160 patients)
METOPROLOL SUCCINATE (159 patients)
AMARYL (158 patients)
ETOPOSIDE (158 patients)
VALPROATE SODIUM (158 patients)
GLEEVEC (158 patients)
MORPHINE SULFATE (157 patients)
PREVISCAN (157 patients)
AMITRIPTYLINE HCL (156 patients)
PREDONINE (156 patients)
LASILIX (156 patients)
ZANTAC (155 patients)
PARACETAMOL (155 patients)
SUNITINIB MALATE (154 patients)
SORAFENIB (154 patients)
ZITHROMAX (154 patients)
TACROLIMUS (153 patients)
NYSTATIN (153 patients)
DOXORUBICIN HCL (153 patients)
ACETYLSALICYLIC ACID SRT (153 patients)
FORTEO (151 patients)
AUGMENTIN '125' (151 patients)
LAMICTAL (151 patients)
VITAMIN E (151 patients)
PRAVASTATIN (150 patients)
KALETRA (149 patients)
GLYBURIDE (145 patients)
REMERON (145 patients)
NAPROXEN (144 patients)
HALDOL (144 patients)
OLANZAPINE (144 patients)
RADIATION THERAPY (144 patients)
RIBAVIRIN (143 patients)
METHYLPREDNISOLONE (143 patients)
VOLTAREN (143 patients)
Most common side effects for patients taking ACAI:
RENAL FAILURE ACUTE (6 patients)
ATRIOVENTRICULAR BLOCK SECOND DEGREE (5 patients)
FALL (5 patients)
NEUROPATHY PERIPHERAL (4 patients)
MEMORY IMPAIRMENT (3 patients)
WEIGHT DECREASED (3 patients)
MUSCLE TWITCHING (3 patients)
FATIGUE (3 patients)
VISUAL ACUITY REDUCED (3 patients)
BALANCE DISORDER (3 patients)
STRESS (3 patients)
EXCORIATION (3 patients)
ERYTHEMA (3 patients)
COGNITIVE DISORDER (3 patients)
COORDINATION ABNORMAL (3 patients)
PAIN (3 patients)
DEHYDRATION (3 patients)
DERMATITIS INFECTED (2 patients)
PRODUCT ADHESION ISSUE (2 patients)
PAIN IN EXTREMITY (2 patients)
RASH (2 patients)
ONYCHOCLASIS (2 patients)
DRY SKIN (2 patients)
ONYCHALGIA (2 patients)
CARPAL TUNNEL SYNDROME (2 patients)
ROTATOR CUFF REPAIR (2 patients)
ROTATOR CUFF SYNDROME (2 patients)
EXOSTOSIS (2 patients)
TRANSITIONAL CELL CARCINOMA (2 patients)
VISUAL IMPAIRMENT (2 patients)
NAUSEA (2 patients)
GASTROENTERITIS VIRAL (2 patients)
NASOPHARYNGITIS (2 patients)
HOT FLUSH (2 patients)
VOMITING (2 patients)
LIMB CRUSHING INJURY (2 patients)
INCISION SITE HAEMORRHAGE (2 patients)
LOWER EXTREMITY MASS (2 patients)
INSOMNIA (1 patients)
KIDNEY INFECTION (1 patients)
ABDOMINAL PAIN (1 patients)
INFLUENZA LIKE ILLNESS (1 patients)
HYPONATRAEMIA (1 patients)
MONOPLEGIA (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE SCLEROSIS RELAPSE (1 patients)
HYPERTENSION (1 patients)
MYALGIA (1 patients)
HERPES ZOSTER (1 patients)
FEELING HOT (1 patients)
EAR INFECTION (1 patients)
NEUTROPENIA (1 patients)
NON-HODGKIN'S LYMPHOMA (1 patients)
DYSPEPSIA (1 patients)
DRUG INEFFECTIVE (1 patients)
OROPHARYNGEAL PAIN (1 patients)
DIZZINESS (1 patients)
DIVERTICULITIS (1 patients)
PHARYNGITIS (1 patients)
DIARRHOEA (1 patients)
PYREXIA (1 patients)
CYSTITIS (1 patients)
RENAL CYST (1 patients)
BLOOD TRIGLYCERIDES INCREASED (1 patients)
RHEUMATOID ARTHRITIS (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLADDER DISORDER (1 patients)
SHOCK (1 patients)
SKIN LACERATION (1 patients)
STAPHYLOCOCCAL INFECTION (1 patients)
BLADDER CANCER (1 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (1 patients)
BASAL CELL CARCINOMA (1 patients)
URTICARIA (1 patients)
UVEITIS (1 patients)
ASTHENIA (1 patients)
ARTHRALGIA (1 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (1 patients)
ACUTE HEPATIC FAILURE (1 patients)
WOUND INFECTION (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACAI


Issue Description / Topic Timestamp
QUESTION
BURNING SENSATION
I have not taken acai berry but have experienced a burning sensation and a tingling "pins and needles" sensation from taking maqui berry capsules. There is very little research on humans on maqui berry's side effects. I am wondering if anyone else has experienced similar. M 2017-05-09 17:39:37

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPONATRAEMIA and ACAI, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACAI, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACAI. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACAI experts. If you are a healthcare provider experienced in prescribing ACAI, please register here.

Your online appointment book for Montauk Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use